These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9384247)

  • 1. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
    Browning RA; Wood AV; Merrill MA; Dailey JW; Jobe PC
    Eur J Pharmacol; 1997 Oct; 336(1):1-6. PubMed ID: 9384247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).
    Dailey JW; Yan QS; Adams-Curtis LE; Ryu JR; Ko KH; Mishra PK; Jobe PC
    Life Sci; 1996; 58(4):259-66. PubMed ID: 8538363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
    Dreshfield LJ; Wong DT; Perry KW; Engleman EA
    Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
    Wada Y; Hirao N; Shiraishi J; Nakamura M; Koshino Y
    Neurosci Lett; 1999 May; 267(1):61-4. PubMed ID: 10400249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
    Dailey JW; Yan QS; Mishra PK; Burger RL; Jobe PC
    J Pharmacol Exp Ther; 1992 Feb; 260(2):533-40. PubMed ID: 1738103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Dailey JW
    Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
    J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats.
    Statnick M; Dailey J; Jobe P; Browning R
    Eur J Pharmacol; 1996 Mar; 299(1-3):93-102. PubMed ID: 8901011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.
    Pasini A; Tortorella A; Gale K
    Brain Res; 1996 Jun; 724(1):84-8. PubMed ID: 8816259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
    Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
    Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the serotonergic terminal fields modulating seizures in the genetically epilepsy-prone rat.
    Merrill MA; Clough RW; Dailey JW; Jobe PC; Browning RA
    Epilepsy Res; 2007 Sep; 76(2-3):93-102. PubMed ID: 17689928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Cheong JH; Ko KH; Dailey JW
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):149-52. PubMed ID: 7527501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N; Blier P
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours.
    Dreshfield LJ; Rocco VP; Wong DT
    Chin J Physiol; 1997 Jun; 40(2):57-61. PubMed ID: 9303241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in 5-HT1A and 5-HT1B receptor binding in severe-seizure genetically epilepsy-prone rats (GEPR-9s).
    Statnick MA; Dailey JW; Jobe PC; Browning RA
    Neuropharmacology; 1996 Jan; 35(1):111-8. PubMed ID: 8684590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.
    Hervás I; Vilaró MT; Romero L; Scorza MC; Mengod G; Artigas F
    Neuropsychopharmacology; 2001 Jan; 24(1):11-20. PubMed ID: 11106871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.
    Dailey JW; Reith ME; Yan QS; Li MY; Jobe PC
    Neurosci Lett; 1997 May; 227(1):13-6. PubMed ID: 9178847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.